An2 Therapeutics, Inc. · NASDAQ:ANTX
An2 Therapeutics, Inc. shareholders
As of Jun 30, 2026, 63 institutions reported holding An2 Therapeutics, Inc., 65.1% of its shares. Largest: Vivo Capital, LLC, Commodore Capital LP and Millennium. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of An2 Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vivo Capital, LLC | 3.15M | 8.4% | no change | Aug 14, 2026 |
| Commodore Capital LP | 2.93M | 7.8% | +600K | Aug 14, 2026 |
| Millennium | 2.32M | 6.1% | +96,190 | Aug 14, 2026 |
| BlackRock | 1.67M | 4.4% | +1.35M | Aug 7, 2026 |
| Spruce Street Capital LP | 1.66M | 4.4% | no change | Aug 13, 2026 |
| Vanguard | 1.62M | 4.3% | +466K | Aug 13, 2026 |
| Almitas Capital LLC | 1.47M | 3.9% | −10,000 | Aug 17, 2026 |
| Adage Capital Partners Gp, L.L.C. | 1M | 2.6% | no change | Aug 14, 2026 |
| Citadel | 952K | 2.5% | +797K | Aug 14, 2026 |
| Boxer Capital Management, LLC | 749K | 2.0% | no change | Aug 14, 2026 |